Filing Flows › Surgery Partners (SGRY) › Guidance & outlook
Surgery Partners (SGRY) guidance and outlook
Surgery Partners' 10-Q filed Nov 9, 2026 makes 6 forward-looking statements.
Guidance and outlook
Forward-looking statements, 10-Q filed Nov 9, 2026
- These statements include, but are not limited to, statements regarding our future financial position, business strategy, budgets, effective tax rate, projected costs and plans and objectives of management for future operations.
- If the Merger is consummated, the Company’s common stock will be delisted from the Nasdaq Global Select Market and deregistered under the Securities Exchange Act of 1934, as amended.
- The Merger Agreement Amendment further provides in the event the requisite Company stockholder approval has been obtained but the Merger has not occurred by March 1, 2027, the Company’s stockholders (other than certain excluded shares, including shares held by rollover stockholders) will receive additional monthly Ticking Fee cash payments, which payments will be paid in equal monthly installments in arrears at a…
- The Company has incurred and expects to incur additional transaction-related costs, including financial advisory, legal, accounting and other professional fees, in connection with the proposed Merger.
- In addition to cash flows from operations and available cash, other sources of capital include amounts available on our Revolver as well as anticipated continued access to the capital markets.
- Based on our current level of operations, we believe cash flows from operations, available cash, available capacity on our Revolver and continued anticipated access to capital markets, will be adequate to meet our short-term (i.e., 12 months) and long-term (beyond 12 months) liquidity needs.
Surgery Partners' latest quarter
Surgery Partners, Q3 2026: revenue $815M (-0.8% year over year), operating margin 10.5%, net earnings $14.1M, operating cash flow $104M. The chart follows the revenue to costs, profit and cash.
Questions
What does Surgery Partners expect?
These statements include, but are not limited to, statements regarding our future financial position, business strategy, budgets, effective tax rate, projected costs and plans and objectives of management for future operations. If the Merger is consummated, the Company’s common stock will be delisted from the Nasdaq Global Select Market and deregistered under the Securities Exchange Act of 1934, as amended. The Merger Agreement Amendment further provides in the event the requisite Company stockholder approval has been obtained but the Merger has not occurred by March 1, 2027, the Company’s sto
Updated Nov 10, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.